Please login to the form below

Not currently logged in
Email:
Password:

Astellas Pharma Europe appoint new senior director, market access

Dr Susan Wood was previously senior brand director of the company’s pain management franchise 

Dr Susan Wood, Astellas Pharma 

Astellas Pharma Europe, the European subsidiary of the Tokyo-based company, has promoted Dr Susan Wood to senior director of market access.

Wood joined the company in 2008, where she was most recently senior brand director for the company's pain management franchise, which she held for three years.

During this time she led the launch of a peripheral neurotic pain treatment Qutenza (capsaicin), which involved an integrated market access approach at an early stage of strategic planning.

Commenting on the appointment, Ken Jones, president and CEO of Astellas Pharma Europe, said: “Sue will be working closely with our affiliates to drive the market access strategy across the Astellas Europe organisation in our key therapeutic areas, focusing on developing evidence-based models from the early stages of R&D until the mature stages of the product lifecycle.”

In her new role Wood will focus on developing the company's market access activities and will report to Kay Drake, vice president marketing.

“I am very much looking forward to the challenge of supporting the company to achieve its strategic objectives,” said Wood.

“Astellas Pharma Europe has recently launched its oncology franchise, we are expecting some 11 products to be in launch or early-growth phase in the next three years.

“We are growing fast in anti-infectives, with the recently launched anti-infective Dificlir, the first new treatment in 50 years for clostridium difficile (C.diff), and we continue to affirm our category leadership in transplantation and urology.”

Wood has more than 13 years' experience in international pharmaceutical marketing, with a particular focus on strategy. Prior to joining Astellas, she held management roles with Hoffman-La Roche, Biogen and Sanofi Pasteur.

14th August 2012

From: Marketing, Healthcare

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...